Patents Examined by Lance W Rider
  • Patent number: 10213421
    Abstract: The present invention relates to pharmaceutical compositions containing one or more compounds of formula 1 wherein R1 is H, C1-6-alkyl, C0-4-alkyl-C3-6-cycloalkyl, C1-6-haloalkyl; R2 is H, C1-6-alkyl; X is an anion selected from the group consisting of chloride or ½ dibenzoyltartrate j is 1 or 2. processes for the preparation thereof, and their use to treat diseases connected with the CCR3 receptor.
    Type: Grant
    Filed: March 27, 2013
    Date of Patent: February 26, 2019
    Assignee: Alkahest, Inc.
    Inventors: Alfred Fetscher, Jochen Matthias Scher
  • Patent number: 10195127
    Abstract: The present invention provides a cosmetic composition containing (A) a powder composed of one or more kinds of the N-medium-chain-acyl basic amino acid powder represented by the following formula (I), (B) an inorganic powder, and (C) an oil material: wherein R is a saturated or unsaturated straight hydrocarbon group having 5-9 carbon atoms, and m is an integer of 1-4.
    Type: Grant
    Filed: September 11, 2015
    Date of Patent: February 5, 2019
    Assignee: AJINOMOTO CO., INC.
    Inventors: Masayuki Kuramoto, Eiko Oshimura
  • Patent number: 10124068
    Abstract: Provided herein are hemostatic compositions. In one embodiment, the hemostatic composition includes cross-linked polymer microspheres, such as cross-linked gelatin microspheres with pores. In another embodiment, the hemostatic composition comprises an additive such as a wetting agent, a suspending agent, or both. The hemostatic compositions may also include a hemostatic agent such as thrombin, and may include a high concentration of thrombin. The hemostatic compositions may also include plasma. Also provided herein are devices for dispersing said hemostatic compositions in a diluent, and delivering said dispersed hemostatic composition. The hemostatic compositions may also fabricated with a selected geometry as administration suggests.
    Type: Grant
    Filed: March 20, 2017
    Date of Patent: November 13, 2018
    Assignee: Baxter International, Inc.
    Inventors: Richard I. Senderoff, Jeffrey D. Meyer, Emily N. Rollins, Steven D. Hughes, Richard M. Garcia, Paul D. Bishop, Gerald W. Lasser
  • Patent number: 10111961
    Abstract: Microparticles and nanoparticles of hydrophobized proteins and an alpha-cyclodextrin, obtained by auto-association in an aqueous medium, the hydrophobized protein being obtained by grafting of alkyl chains coming from fatty acids, by an acylation reaction. These microparticles and nanoparticles constitute systems used for encapsulation of active substances of interest, in particular in the pharmaceutical field, and the vectorization thereof for therapeutic purposes.
    Type: Grant
    Filed: May 2, 2014
    Date of Patent: October 30, 2018
    Assignees: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE PARIS-SUD XI
    Inventor: Kawthar Bouchemal
  • Patent number: 10106562
    Abstract: This application relates to a process for making a pharmaceutically acceptable formulation of gadofosveset trisodium monohydrate, wherein the process uses no more than one chromatographic purification for removal of impurities.
    Type: Grant
    Filed: March 13, 2014
    Date of Patent: October 23, 2018
    Assignee: Lantheus Medical Imaging, Inc.
    Inventors: Tarakeshwar Anklekar, Jan Haller, Nicolas Champion, Franz-Willi Herkenrath
  • Patent number: 10080822
    Abstract: The present application discloses the use of a polyurethane material in the preparation of a latex product, wherein the polyurethane material comprises a waterborne polyurethane and nano-silver. The polyurethane material of the present application is made of a combination of a waterborne polyurethane and nano-silver, which gives rise to the said latex products not only having a broad spectrum of antimicrobial activity including inactivating HIV-1 and HSV, but also having the ability to inactivate the microorganism in a short time.
    Type: Grant
    Filed: April 21, 2017
    Date of Patent: September 25, 2018
    Inventors: Rulin Chen, Victor W J Chan
  • Patent number: 10071068
    Abstract: Sustained release oral dosage forms of an R-baclofen prodrug are disclosed.
    Type: Grant
    Filed: March 3, 2010
    Date of Patent: September 11, 2018
    Assignee: XENOPORT, INC.
    Inventors: David E. Edgren, David J. Kidney, Nikhil Pargaonkar, Derrick K. Kim, Gorm Yoder, Sarni Karaborni
  • Patent number: 9999588
    Abstract: A natural and dual-functioning topical skin care composition for exfoliating and moisturizing the skin. The compositions include undissolved, water-soluble Camu Camu particles as an exfoliant in a pharmaceutically acceptable carrier. The compositions are anhydrous or substantially free of water to retain the exfoliant Camu Camu particles in the composition as it is applied and rubbed onto the skin. The compositions provide a rinse-free way to exfoliate the skin with the application of minute amounts of water to dissolve the vitamin C enriched Camu Camu particles of the compositions that may then be absorbed into the skin.
    Type: Grant
    Filed: February 16, 2016
    Date of Patent: June 19, 2018
    Inventors: Lisa Stewart, Ara Asadorian
  • Patent number: 9974868
    Abstract: Disclosed are nanoparticles comprising octapod iron oxide having eight trigonal bipyramidal arms and a method of preparing the same. The nanoparticles are prepared by heating a mixture of a ferric carboxylate, a carboxylic acid, a chloride salt, water, and a non-polar solvent, to a temperature above about 300° C. Also disclosed is a method of magnetic resonance imaging a tissue in a mammal, comprising use of the aforesaid nanoparticles.
    Type: Grant
    Filed: June 3, 2013
    Date of Patent: May 22, 2018
    Assignees: The United States of America, as represented by the Secretary, Department of Health and Human Services, Xiamen University
    Inventors: Jinhao Gao, Xiaoyuan Chen, Zenghuan Zhao
  • Patent number: 9968692
    Abstract: The present invention provides a nanobubble comprising a continuous outer shell, the outer shell comprising a cross-linked polymeric material, an inner wall of the continuous outer shell and a hollow core within the continuous outer shell. The nanobubble may be less than 250 nm in diameter. In a further aspect of the invention, the cross-linked polymeric material is a cellulose-based material.
    Type: Grant
    Filed: October 2, 2015
    Date of Patent: May 15, 2018
    Assignee: PURDUE RESEARCH FOUNDATION
    Inventors: Joseph Irudayaraj, Pushpak Bhandari
  • Patent number: 9949929
    Abstract: A drug carrier and a manufacturing method thereof are provided. The drug carrier includes a hydrophilic group, a hydrophobic group and an organic dye. The hydrophilic group and the hydrophobic group are connected by the organic dye. A plurality of the drug carriers are self-assemblable in a polar solvent to form a nanomicelle. The hydrophilic groups are located at the outer region of the nanomicelle, and the hydrophobic groups are located at the inner region of the nanomicelle.
    Type: Grant
    Filed: December 3, 2015
    Date of Patent: April 24, 2018
    Assignee: NATIONAL TAIWAN UNIVERSITY HOSPITAL
    Inventors: Ming-Jium Shieh, Cheng-Liang Peng, Yuan-I Chen
  • Patent number: 9889098
    Abstract: The subject invention relates to novel micoparticulate and soluble forms of flavonoids, and their synthesis. The invention also includes novel formulations of such flavonoids. Further, the invention includes novel methods of manufacturing the flavonoid formulations. The invention also relates to a wide variety of applications of the flavonoid formulations.
    Type: Grant
    Filed: October 22, 2010
    Date of Patent: February 13, 2018
    Assignee: VIZURI HEALTH SCIENCES LLC
    Inventor: Philip J. Birbara
  • Patent number: 9072688
    Abstract: Certain embodiments disclosed herein relate to compositions, methods, devices, systems, and products regarding frozen particles. In certain embodiments, the frozen particles include materials at low temperatures. In certain embodiments, the frozen particles provide vehicles for delivery of particular agents. In certain embodiments, the frozen particles are administered to at least one biological tissue.
    Type: Grant
    Filed: October 31, 2008
    Date of Patent: July 7, 2015
    Assignee: The Invention Science Fund I, LLC
    Inventors: Edward S. Boyden, Roderick A. Hyde, Eric C. Leuthardt, Nathan P. Myhrvold, Elizabeth A. Sweeney, Lowell L. Wood, Jr.
  • Patent number: 9060934
    Abstract: Certain embodiments disclosed herein relate to compositions, methods, devices, systems, and products regarding frozen particles. In certain embodiments, the frozen particles include materials at low temperatures. In certain embodiments, the frozen particles provide vehicles for delivery of particular agents. In certain embodiments, the frozen particles are administered to at least one biological tissue.
    Type: Grant
    Filed: February 26, 2009
    Date of Patent: June 23, 2015
    Assignee: The Invention Science Fund I, LLC
    Inventors: Edward S. Boyden, Daniel B. Cook, Roderick A. Hyde, Eric C. Leuthardt, Nathan P. Myhrvold, Elizabeth A. Sweeney, Lowell L. Wood, Jr.
  • Patent number: 9060926
    Abstract: Certain embodiments disclosed herein relate to compositions, methods, devices, systems, and products regarding frozen particles. In certain embodiments, the frozen particles include materials at low temperatures. In certain embodiments, the frozen particles provide vehicles for delivery of particular agents. In certain embodiments, the frozen particles are administered to at least one biological tissue.
    Type: Grant
    Filed: October 31, 2008
    Date of Patent: June 23, 2015
    Assignee: The Invention Science Fund I, LLC
    Inventors: Edward S. Boyden, Roderick A. Hyde, Eric C. Leuthardt, Nathan P. Myhrvold, Elizabeth A. Sweeney, Lowell L. Wood, Jr.
  • Patent number: 9060931
    Abstract: Certain embodiments disclosed herein relate to compositions, methods, devices, systems, and products regarding frozen particles. In certain embodiments, the frozen particles include materials at low temperatures. In certain embodiments, the frozen particles provide vehicles for delivery of particular agents. In certain embodiments, the frozen particles are administered to at least one biological tissue.
    Type: Grant
    Filed: March 20, 2009
    Date of Patent: June 23, 2015
    Assignee: The Invention Science Fund I, LLC
    Inventors: Edward S. Boyden, Daniel B. Cook, Roderick A. Hyde, Eric C. Leuthardt, Nathan P. Myhrvold, Elizabeth A. Sweeney, Lowell L. Wood, Jr.
  • Patent number: 9056047
    Abstract: Certain embodiments disclosed herein relate to compositions, methods, devices, systems, and products regarding frozen particles. In certain embodiments, the frozen particles include materials at low temperatures. In certain embodiments, the frozen particles provide vehicles for delivery of particular agents. In certain embodiments, the frozen particles are administered to at least one biological tissue.
    Type: Grant
    Filed: March 20, 2009
    Date of Patent: June 16, 2015
    Assignee: The Invention Science Fund I, LLC
    Inventors: Edward S. Boyden, Daniel B. Cook, Roderick A. Hyde, Eric C. Leuthardt, Nathan P. Myhrvold, Elizabeth A. Sweeney, Lowell L. Wood, Jr.
  • Patent number: 9050251
    Abstract: Certain embodiments disclosed herein relate to compositions, methods, devices, systems, and products regarding frozen particles. In certain embodiments, the frozen particles include materials at low temperatures. In certain embodiments, the frozen particles provide vehicles for delivery of particular agents. In certain embodiments, the frozen particles are administered to at least one biological tissue.
    Type: Grant
    Filed: March 20, 2009
    Date of Patent: June 9, 2015
    Assignee: The Invention Science Fund I, LLC
    Inventors: Edward S. Boyden, Daniel B. Cook, Roderick A. Hyde, Eric C. Leuthardt, Nathan P. Myhrvold, Elizabeth A. Sweeney, Lowell L. Wood, Jr.
  • Patent number: 9050070
    Abstract: Certain embodiments disclosed herein relate to compositions, methods, devices, systems, and products regarding frozen particles. In certain embodiments, the frozen particles include materials at low temperatures. In certain embodiments, the frozen particles provide vehicles for delivery of particular agents. In certain embodiments, the frozen particles are administered to at least one biological tissue.
    Type: Grant
    Filed: February 26, 2009
    Date of Patent: June 9, 2015
    Assignee: The Invention Science Fund I, LLC
    Inventors: Edward S. Boyden, Daniel B. Cook, Roderick A. Hyde, Eric C. Leuthardt, Nathan P. Myhrvold, Elizabeth A. Sweeney, Lowell L. Wood, Jr.
  • Patent number: 9050317
    Abstract: Certain embodiments disclosed herein relate to compositions, methods, devices, systems, and products regarding frozen particles. In certain embodiments, the frozen particles include materials at low temperatures. In certain embodiments, the frozen particles provide vehicles for delivery of particular agents. In certain embodiments, the frozen particles are administered to at least one biological tissue.
    Type: Grant
    Filed: October 31, 2008
    Date of Patent: June 9, 2015
    Assignee: The Invention Science Fund I, LLC
    Inventors: Edward S. Boyden, Roderick A. Hyde, Eric C. Leuthardt, Nathan P. Myhrvold, Elizabeth A. Sweeney, Lowell L. Wood, Jr.